Currently holds a position at Apellis Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
President, Chief Executive Officer, Co-Founder, Director | Apellis Pharmaceuticals Inc | Jan. 1, 2016 - |
President, Chief Executive Officer, Director | Apellis Pharmaceuticals Inc | Sept. 1, 2009 - Jan. 1, 2016 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-02-13 | 2024-02-12 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
3,962
-1.2%
67.77268,492 USD |
3,962 -1.2% | 67.77 | 268,492 USD | |
2024-01-31 | 2024-01-29 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
2,843
-0.9%
64.14182,345 USD |
2,843 -0.9% | 64.14 | 182,345 USD | |
2024-01-23 | 2024-01-22 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
13,431
-4.0%
65.00872,961 USD |
13,431 -4.0% | 65.00 | 872,961 USD | |
2024-01-17 | 2024-01-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
7,851
-2.3%
66.81524,514 USD |
7,851 -2.3% | 66.81 | 524,514 USD | |
2023-11-21 | 2023-11-21 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
5,000
-1.8%
48.80244,000 USD |
5,000 -1.8% | 48.80 | 244,000 USD | |
2023-09-01 | 2023-09-01 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
10,284
-2.4%
42.44436,453 USD |
10,284 -2.4% | 42.44 | 436,453 USD | |
2023-09-01 | 2023-09-01 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
139,716
-24.3%
41.705,826,506 USD |
139,716 -24.3% | 41.70 | 5,826,506 USD | |
2023-05-18 | 2023-05-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
2,120
-0.8%
87.67185,869 USD |
2,120 -0.8% | 87.67 | 185,869 USD | |
2023-05-18 | 2023-05-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
7,528
-2.6%
87.02655,059 USD |
7,528 -2.6% | 87.02 | 655,059 USD | |
2023-05-18 | 2023-05-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
3,007
-1.0%
85.90258,305 USD |
3,007 -1.0% | 85.90 | 258,305 USD | |
2023-05-18 | 2023-05-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
14,611
-4.8%
85.011,242,065 USD |
14,611 -4.8% | 85.01 | 1,242,065 USD | |
2023-05-18 | 2023-05-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
1,800
-0.6%
83.85150,921 USD |
1,800 -0.6% | 83.85 | 150,921 USD | |
2023-05-18 | 2023-05-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
934
-0.3%
83.1777,682 USD |
934 -0.3% | 83.17 | 77,682 USD | |
2023-04-20 | 2023-04-18 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
30,000
-4.5%
82.022,460,720 USD |
30,000 -4.5% | 82.02 | 2,460,720 USD | |
2022-12-21 | 2022-12-19 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
24,449
-2.5%
52.071,273,052 USD |
24,449 -2.5% | 52.07 | 1,273,052 USD | |
2020-12-16 | 2020-12-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
5,000
-0.4%
52.16260,800 USD |
5,000 -0.4% | 52.16 | 260,800 USD | |
2020-11-17 | 2020-11-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
5,000
-0.5%
39.38196,900 USD |
5,000 -0.5% | 39.38 | 196,900 USD | |
2020-10-16 | 2020-10-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
5,000
-0.5%
34.46172,300 USD |
5,000 -0.5% | 34.46 | 172,300 USD | |
2020-09-16 | 2020-09-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
5,000
-0.5%
30.96154,800 USD |
5,000 -0.5% | 30.96 | 154,800 USD | |
2020-08-21 | 2020-08-20 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
3,457
-0.3%
30.00103,710 USD |
3,457 -0.3% | 30.00 | 103,710 USD | |
2020-08-20 | 2020-08-18 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
1,543
-0.1%
30.0046,290 USD |
1,543 -0.1% | 30.00 | 46,290 USD | |
2020-07-16 | 2020-07-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
5,000
-0.5%
32.12160,600 USD |
5,000 -0.5% | 32.12 | 160,600 USD | |
2020-06-16 | 2020-06-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
5,000
-0.5%
30.21151,050 USD |
5,000 -0.5% | 30.21 | 151,050 USD | |
2020-05-19 | 2020-05-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
5,000
-0.4%
29.92149,600 USD |
5,000 -0.4% | 29.92 | 149,600 USD | |
2020-04-17 | 2020-04-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
5,000
-0.4%
29.77148,850 USD |
5,000 -0.4% | 29.77 | 148,850 USD | |
2020-03-18 | 2020-03-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
300
-0.0%
23.867,158 USD |
300 -0.0% | 23.86 | 7,158 USD | |
2020-03-18 | 2020-03-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
3,212
-0.3%
22.2871,557 USD |
3,212 -0.3% | 22.28 | 71,557 USD | |
2020-03-18 | 2020-03-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
15,065
-1.4%
21.58325,088 USD |
15,065 -1.4% | 21.58 | 325,088 USD | |
2020-03-18 | 2020-03-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
12,060
-1.1%
20.69249,558 USD |
12,060 -1.1% | 20.69 | 249,558 USD | |
2020-03-18 | 2020-03-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
700
-0.1%
22.2915,600 USD |
700 -0.1% | 22.29 | 15,600 USD | |
2020-03-18 | 2020-03-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
2,192
-0.2%
21.5747,279 USD |
2,192 -0.2% | 21.57 | 47,279 USD | |
2020-03-18 | 2020-03-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
2,108
-0.2%
20.7343,695 USD |
2,108 -0.2% | 20.73 | 43,695 USD | |
2020-02-20 | 2020-02-18 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
5,000
-0.5%
40.67203,330 USD |
5,000 -0.5% | 40.67 | 203,330 USD | |
2020-02-20 | 2020-02-18 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
30,637
-2.9%
40.661,245,792 USD |
30,637 -2.9% | 40.66 | 1,245,792 USD | |
2020-01-17 | 2020-01-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
5,000
-0.5%
41.47207,350 USD |
5,000 -0.5% | 41.47 | 207,350 USD | |
2020-01-17 | 2020-01-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
4,562
-0.5%
42.55194,099 USD |
4,562 -0.5% | 42.55 | 194,099 USD | |
2020-01-17 | 2020-01-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
26,076
-2.5%
42.161,099,338 USD |
26,076 -2.5% | 42.16 | 1,099,338 USD | |
2019-10-16 | 2019-10-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
3,524
-0.3%
26.6193,784 USD |
3,524 -0.3% | 26.61 | 93,784 USD | |
2019-10-16 | 2019-10-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
1,476
-0.1%
25.5937,766 USD |
1,476 -0.1% | 25.59 | 37,766 USD | |
2019-09-17 | 2019-09-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
260
-0.0%
27.177,064 USD |
260 -0.0% | 27.17 | 7,064 USD | |
2019-09-17 | 2019-09-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
4,740
-0.5%
26.56125,885 USD |
4,740 -0.5% | 26.56 | 125,885 USD |